Expression of nitric oxide synthase isoforms in the ovine fetal brain: alteration by hormonal and hemodynamic stimuli.
OBJECTIVE
Nitric oxide (NO) is synthesized in the brain through the action of three isoforms of nitric oxide synthase (NOS). The local generation of NO in neurons, glia, and vasculature modulates neuronal activity, as well as regional cerebral blood flow. We propose that, in the fetal brain, cerebral hypoperfusion alters the expression of NOS isoforms, and that estrogen administration modulates the NOS response to hypoperfusion.


METHODS
Sixteen chronically catheterized fetal sheep of known gestational age (124 to 128 days' gestation) were subjected to a 10-minute period of brachiocephalic occlusion (BCO) or to sham BCO; half of these fetuses were subjected to subcutaneous implant, which released 17beta-estradiol (E2; 0.25 mg/d) or placebo. Brain tissue was collected for mRNA and protein extraction 1 hour after the start of the BCO or sham BCO.


RESULTS
All three isoforms of NOS were identified in fetal brain at both the mRNA and protein levels. BCO increased NOS1 (hippocampus, brainstem), NOS2 (hypothalamus), and NOS3 (hippocampus, cortex) at the protein level. Estradiol alone increased NOS1 (brainstem, cortex), NOS2 (hippocampus, hypothalamus), and NOS3 (brainstem, cerebellum) at the protein level, changes that were not mirrored at the mRNA level. The combination of BCO and estradiol produced smaller changes in NOS1 (brainstem, cortex), NOS2 (hippocampus, hypothalamus), and NOS3 (brainstem) protein levels than those produced by either stimulus alone.


CONCLUSIONS
We conclude that the fetal brain expresses all isoforms of NOS, and that NOS expression is altered by both BCO and estradiol, but that the most prevalent effect of estradiol is to reduce specific NOS responses to cerebral hypoperfusion. The present results suggest the possibility that the neuroendocrine responses to estradiol and BCO are modulated by central nervous system (CNS) NO biosynthesis.
Wood
Charles E
CE
Department of Physiology and Functional Genomics, University of Florida College of Medicine, Gainesville, Florida 32610-0274, USA. cwood@phys.med.ufl.edu
Giroux
Damian
D
D000818:Animals; D001921:Brain / Q000196:embryology* / Q000201:enzymology*; D001933:Brain Stem / Q000201:enzymology; D002540:Cerebral Cortex / Q000201:enzymology; D004958:Estradiol / Q000008:administration & dosage*; D015870:Gene Expression / Q000187:drug effects; D005865:Gestational Age; D006439:Hemodynamics; D006624:Hippocampus / Q000201:enzymology; D007031:Hypothalamus / Q000201:enzymology; D007527:Isoenzymes / Q000032:analysis / Q000235:genetics; D019001:Nitric Oxide Synthase / Q000032:analysis / Q000235:genetics*; D052248:Nitric Oxide Synthase Type I / Q000032:analysis / Q000235:genetics; D052247:Nitric Oxide Synthase Type II / Q000032:analysis / Q000235:genetics; D052250:Nitric Oxide Synthase Type III / Q000032:analysis / Q000235:genetics; D010902:Pituitary Gland / Q000196:embryology / Q000201:enzymology; D010919:Placebos; D012333:RNA, Messenger / Q000032:analysis; D012756:Sheep / Q000196:embryology*
D007527:Isoenzymes; D010919:Placebos; D012333:RNA, Messenger; D004958:Estradiol; D019001:Nitric Oxide Synthase; D052248:Nitric Oxide Synthase Type I; D052247:Nitric Oxide Synthase Type II; D052250:Nitric Oxide Synthase Type III